MedPath

NITROGLYCERIN

Nitroglycerin Sublingual Tablets, USP

Approved
Approval ID

4cc78c9d-ff20-2685-e054-00144ff88e88

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 4, 2019

Manufacturers
FDA

Sina Health Inc

DUNS: 047161553

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

nitroglycerin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70385-2018
Application NumberNDA021134
Product Classification
M
Marketing Category
C73605
G
Generic Name
nitroglycerin
Product Specifications
Route of AdministrationSUBLINGUAL
Effective DateFebruary 4, 2019
FDA Product Classification

INGREDIENTS (6)

LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
GLYCERYL MONOSTEARATEInactive
Code: 230OU9XXE4
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
NITROGLYCERINActive
Quantity: 0.4 mg in 1 1
Code: G59M7S0WS3
Classification: ACTIB
CALCIUM STEARATEInactive
Code: 776XM7047L
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NITROGLYCERIN - FDA Drug Approval Details